CompletedPhase 2

Transdermal Contraceptive Patch - Endometrial Effects Study

Germany92 participantsStarted 2009-07

Plain-language summary

The aim of the present study is to investigate the effects of the transdermal patch on the endometrium in healthy women who require contraception.

Who can participate

Age range18 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Requiring contraception * Normal cervical smear * Smokers not older than 30 years * History of regular cyclic menstrual periods Exclusion Criteria: * Pregnancy or lactation * Obesity (BMI\> 30 kg/m2) * Significant skin reaction to transdermal preparations or sensitivity to surgical / medical tape * Any disease that may worsen under hormonal treatment (cardiovascular, liver, metabolic) * Use of other contraceptive methods than study medication

What they're measuring

Effect on the endometrium at cycle 13

Timeframe: 13 treatment cycles (each consisting of 28 days)

Trial details

NCT IDNCT00896571

SponsorBayer

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2011-05

View on ClinicalTrials.gov More Contraception trials